You are here
Teva wins US nod for Actavis after divestiture of 79 drugs
THE US Federal Trade Commission (FTC) has approved Teva Pharmaceutical Industries Ltd's US$40.5 billion purchase of Allergan Plc's generic drug-making unit after the companies agreed to the biggest divestiture ever in a pharmaceutical merger to preserve competition.
- CALL +65 6388 3838
- EMAIL email@example.com